Monkey Pox Treatment Global Market Report 2025

Description

Monkeypox treatment involves medical interventions and therapies designed to manage and alleviate the symptoms of monkeypox, a viral disease caused by the monkeypox virus. These treatments include various therapeutic and supportive approaches aimed at reducing disease severity and enhancing patient outcomes.

The primary types of monkeypox treatment are prophylactic vaccines and therapeutics. Prophylactic vaccines are intended to prevent monkeypox infection by boosting the immune system to recognize and combat the virus, particularly in high-risk populations and during outbreaks to limit the virus's spread. Treatment dosage forms include solid, liquid, and semisolid, with administration routes such as oral, topical, and parenteral. These treatments are distributed through retail pharmacies, hospital pharmacies, and online pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The monkey pox treatment market research report is one of a series of new reports from the business research company that provides monkey pox treatment market statistics, including monkey pox treatment industry global market size, regional shares, competitors with an monkey pox treatment market share, detailed monkey pox treatment market segments, market trends and opportunities, and any further data you may need to thrive in the monkey pox treatment industry. This monkey pox treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The monkey pox treatment market size has grown rapidly in recent years. It will grow from $0.09 billion in 2024 to $0.1 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to outbreaks in endemic regions, zoonotic transmission awareness, smallpox eradication legacy, public health initiatives, emergence of human cases.

The monkey pox treatment market size is expected to see rapid growth in the next few years. It will grow to $0.16 billion in 2029 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to globalization and travel, government funding and support, biotech and pharmaceutical investment, public health surveillance, and regulatory approvals. Major trends in the forecast period include antiviral drug development, use of smallpox vaccines, monoclonal antibodies, combination therapies, and long-term immunity research.

The forecast of 13.0% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden healthcare systems by driving up the cost of tecovirimat capsules and vaccinia immune globulin sourced from the UK and Sweden, exacerbating treatment access challenges during public health emergencies. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The monkeypox (mpox) treatment market is expected to expand due to the rising prevalence of zoonotic infections. Zoonotic infections are diseases that transfer from animals to humans through direct contact with contaminated environments or vectors. Increased human-animal interaction, which brings people and animals into closer proximity, heightens the risk of zoonotic infections. Additionally, climate change exacerbates this risk by expanding the range of disease vectors and introducing pathogens to new regions. Treatments for monkeypox are designed to manage the zoonotic mpox virus and alleviate symptoms in both humans and potentially infected animals. For example, a report from the UK Health Security Agency in August 2024 indicated 3,732 confirmed cases of mpox in the UK, an increase from 3,753 cases in 2023. This growing prevalence of zoonotic infections is driving demand for monkeypox treatments.

Companies in the monkeypox treatment market are focusing on remote monitoring and teletherapy solutions, such as virtual care, to improve accessibility, streamline patient management, and enhance treatment outcomes. Virtual care for monkeypox involves remote medical consultations, symptom evaluation, and management strategies for individuals at risk or infected, thus facilitating access to care and reducing the need for in-person visits. For instance, in August 2022, Folx Health, a US-based healthcare company, launched Monkeypox Care, a virtual primary care service for those at risk of or affected by monkeypox. This service offers education, counseling, symptom evaluation, and referrals, aiming to reach individuals in underserved areas with limited healthcare access.

In August 2024, Bilthoven Biologicals, a Netherlands-based provider of vaccines and biopharmaceuticals, entered into a partnership with Tonix Pharmaceuticals. The collaboration is focused on accelerating the development of TNX-801, a potential vaccine for preventing mpox, smallpox, and other infectious diseases. Tonix Pharmaceuticals, a US-based pharmaceutical company, is engaged in developing vaccines for monkeypox treatment.

Major companies operating in the monkey pox treatment market are Roche Holding AG, Merck & Co. Inc., Sanofi S.A., Gilead Sciences Inc., BioNTech SE, Moderna Inc., Quest Diagnostics Incorporated, Novavax Inc., Laboratory Corporation of America Holdings, Emergent BioSolutions Inc., Bavarian Nordic A/S, Aegis Sciences Corporation, Daan Gene Co. Ltd., Sansure Biotech Inc., SIGA Technologies Inc., Elabscience Biotechnology Inc., Mayo Clinic Laboratories, Tonix Pharmaceuticals Holding Corp., Altona Diagnostics GmbH, Lansion Biotechnology Co. Ltd., Goldsite Diagnostics Inc., Chimerix Inc., Emcure Pharmaceuticals Ltd., VBI Vaccines Inc

North America was the largest region in the monkey pox treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the monkey pox treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The monkey pox treatment market consists of sales of treatment products such as antiviral medications, vaccine administration devices, supportive care products, infection control supplies, and Reagents and assays for monkeypox research and diagnostic development. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Monkey Pox Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on monkey pox treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for monkey pox treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The monkey pox treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment Type: Prophylactic Vaccines; Therapeutics
2) By Dosage Forms: Solid; Liquid; Semi Solid
3) By Route Of Administration: Oral; Topical; Parenteral
4) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Pharmacies
Subsegments:
1) By Prophylactic Vaccines: Vaccinia-Based Vaccines; Modified Vaccinia Ankara (MVA) Vaccines; Other Vaccines (Recombinant Vaccines)
2) By Therapeutics: Antiviral Agents (Tecovirimat, Brincidofovir); Immune Modulators; Supportive Care Treatments
Companies Mentioned: Roche Holding AG; Merck & Co. Inc.; Sanofi S.A.; Gilead Sciences Inc.; BioNTech SE; Moderna Inc.; Quest Diagnostics Incorporated; Novavax Inc.; Laboratory Corporation of America Holdings; Emergent BioSolutions Inc.; Bavarian Nordic A/S; Aegis Sciences Corporation; Daan Gene Co. Ltd.; Sansure Biotech Inc.; SIGA Technologies Inc.; Elabscience Biotechnology Inc.; Mayo Clinic Laboratories; Tonix Pharmaceuticals Holding Corp.; Altona Diagnostics GmbH; Lansion Biotechnology Co. Ltd.; Goldsite Diagnostics Inc.; Chimerix Inc.; Emcure Pharmaceuticals Ltd.; VBI Vaccines Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r30725u

1. Executive Summary

2. Monkey Pox Treatment Market Characteristics

3. Monkey Pox Treatment Market Trends And Strategies

4. Monkey Pox Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Monkey Pox Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Monkey Pox Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Monkey Pox Treatment Market Growth Rate Analysis
5.4. Global Monkey Pox Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Monkey Pox Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Monkey Pox Treatment Total Addressable Market (TAM)

6. Monkey Pox Treatment Market Segmentation

6.1. Global Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prophylactic Vaccines
Therapeutics
6.2. Global Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Solid
Liquid
Semi Solid
6.3. Global Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Topical
Parenteral
6.4. Global Monkey Pox Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
6.5. Global Monkey Pox Treatment Market, Sub-Segmentation Of Prophylactic Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vaccinia-Based Vaccines
Modified Vaccinia Ankara (MVA) Vaccines
Other Vaccines (Recombinant Vaccines)
6.6. Global Monkey Pox Treatment Market, Sub-Segmentation Of Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antiviral Agents (Tecovirimat, Brincidofovir)
Immune Modulators
Supportive Care Treatments

7. Monkey Pox Treatment Market Regional And Country Analysis

7.1. Global Monkey Pox Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Monkey Pox Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Monkey Pox Treatment Market

8.1. Asia-Pacific Monkey Pox Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Monkey Pox Treatment Market

9.1. China Monkey Pox Treatment Market Overview
9.2. China Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Monkey Pox Treatment Market

10.1. India Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Monkey Pox Treatment Market

11.1. Japan Monkey Pox Treatment Market Overview
11.2. Japan Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Monkey Pox Treatment Market

12.1. Australia Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Monkey Pox Treatment Market

13.1. Indonesia Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Monkey Pox Treatment Market

14.1. South Korea Monkey Pox Treatment Market Overview
14.2. South Korea Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Monkey Pox Treatment Market

15.1. Western Europe Monkey Pox Treatment Market Overview
15.2. Western Europe Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Monkey Pox Treatment Market

16.1. UK Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Monkey Pox Treatment Market

17.1. Germany Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Monkey Pox Treatment Market

18.1. France Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Monkey Pox Treatment Market

19.1. Italy Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Monkey Pox Treatment Market

20.1. Spain Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Monkey Pox Treatment Market

21.1. Eastern Europe Monkey Pox Treatment Market Overview
21.2. Eastern Europe Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Monkey Pox Treatment Market

22.1. Russia Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Monkey Pox Treatment Market

23.1. North America Monkey Pox Treatment Market Overview
23.2. North America Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Monkey Pox Treatment Market

24.1. USA Monkey Pox Treatment Market Overview
24.2. USA Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Monkey Pox Treatment Market

25.1. Canada Monkey Pox Treatment Market Overview
25.2. Canada Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Monkey Pox Treatment Market

26.1. South America Monkey Pox Treatment Market Overview
26.2. South America Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Monkey Pox Treatment Market

27.1. Brazil Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Monkey Pox Treatment Market

28.1. Middle East Monkey Pox Treatment Market Overview
28.2. Middle East Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Monkey Pox Treatment Market

29.1. Africa Monkey Pox Treatment Market Overview
29.2. Africa Monkey Pox Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Monkey Pox Treatment Market, Segmentation By Dosage Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Monkey Pox Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Monkey Pox Treatment Market Competitive Landscape And Company Profiles

30.1. Monkey Pox Treatment Market Competitive Landscape
30.2. Monkey Pox Treatment Market Company Profiles
- 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. BioNTech SE Overview, Products and Services, Strategy and Financial Analysis

31. Monkey Pox Treatment Market Other Major And Innovative Companies

31.1. Moderna Inc.
31.2. Quest Diagnostics Incorporated
31.3. Novavax Inc.
31.4. Laboratory Corporation of America Holdings
31.5. Emergent BioSolutions Inc.
31.6. Bavarian Nordic A/S
31.7. Aegis Sciences Corporation
31.8. Daan Gene Co. Ltd.
31.9. Sansure Biotech Inc.
31.10. SIGA Technologies Inc.
31.11. Elabscience Biotechnology Inc.
31.12. Mayo Clinic Laboratories
31.13. Tonix Pharmaceuticals Holding Corp.
31.14. Altona Diagnostics GmbH
31.15. Lansion Biotechnology Co. Ltd.

32. Global Monkey Pox Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Monkey Pox Treatment Market

34. Recent Developments In The Monkey Pox Treatment Market

35. Monkey Pox Treatment Market High Potential Countries, Segments and Strategies

35.1 Monkey Pox Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Monkey Pox Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Monkey Pox Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer